Skip to main content
Contact Us
Subscribe
E-Edition
70°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eledon Pharmaceuticals Inc
(NQ:
ELDN
)
1.210
-0.020 (-1.63%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 22, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eledon Pharmaceuticals Inc
< Previous
1
2
Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 02, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 25, 2023
On Tuesday, 56 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
June 15, 2023
On Thursday, 64 companies achieved new lows for the year.
Via
Benzinga
Why Chewy Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
June 01, 2023
Gainers Airspan Networks Holdings Inc. (NYSE: MIMO) shares rose 58.9% to $0.3754 in pre-market trading. Airspan Networks recently reported new financing and leadership changes.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
June 01, 2023
It's time to start the day with a breakdown of the biggest pre-market stock movers that traders need to know about for Thursday morning!
Via
InvestorPlace
Recap: Eledon Pharma Q1 Earnings
May 11, 2023
Via
Benzinga
Eledon Pharma's Earnings: A Preview
May 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 13, 2023
Via
Benzinga
Eledon Pharmaceuticals's Earnings: A Preview
March 29, 2023
Via
Benzinga
Eledon Pharma: Q2 Earnings Insights
August 11, 2022
Eledon Pharma (NASDAQ:ELDN) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:01 PM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 30, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 21, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 06, 2022
Gainers Metacrine (NASDAQ:MTCR) shares rose 13.8% to $0.54 during Tuesday's after-market session. This security traded at a volume of 3.0 million shares come close, making up 948.6% of its average...
Via
Benzinga
Eledon Shares Climb After Securing FDA Nod For Mid-Stage Kidney Disease Study
September 06, 2022
Eledon Pharmaceuticals (NASDAQ: ELDN) received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to evaluate tegoprubart for the treatment of...
Via
Benzinga
Eledon Pharmaceuticals Earnings: A Preview
August 10, 2022
Eledon Pharmaceuticals (NASDAQ:ELDN) is set to give its latest quarterly earnings report on Thursday, 2022-08-11. Here's what investors need to know before the announcement.
Via
Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 01, 2022
Via
Benzinga
Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
August 01, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Eledon Secures FDA Clearance For Kidney Transplant Rejection Study
August 01, 2022
The U.S. Food and Drug Administration (FDA) has cleared the Eledon Pharmaceuticals’ (NASDAQ: ELDN) Investigational New Drug (IND) application to evaluate Tegoprubart for the prevention of organ...
Via
Benzinga
Recap of Monday's Biotech Catalysts - End of the Day Summary
July 18, 2022
Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least...
Via
Benzinga
Eledon Pharmaceuticals' Stock Gains As FDA Grants Orphan Drug Designation
June 09, 2022
Eledon Pharmaceuticals (NASDAQ: ELDN) received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for its drug candidate Tegoprubart for the Prevention of Allograft Rejection in...
Via
Benzinga
The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data
June 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 07, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 31, 2022
Via
Benzinga
88 Biggest Movers From Yesterday
May 27, 2022
Gainers Creatd, Inc. (NASDAQ: CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit.
Via
Benzinga
Eledon Pharma: Q1 Earnings Insights
May 12, 2022
Eledon Pharma (NASDAQ:ELDN) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Eledon Pharma missed estimated...
Via
Benzinga
Earnings Outlook For Eledon Pharmaceuticals
May 11, 2022
Eledon Pharmaceuticals (NASDAQ:ELDN) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
March 25, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
March 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Scheduled For March 24, 2022
March 24, 2022
Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter. • Pioneer Muni High Inc (NYSE:MAV) is expected to...
Via
Benzinga
A Preview Of Eledon Pharmaceuticals's Earnings
March 23, 2022
Eledon Pharmaceuticals (NASDAQ:ELDN) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement....
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.